Literature DB >> 30089715

Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction.

Moumita Paul-Heng1, Mario Leong1, Eithne Cunningham1, Daniel L J Bunker1, Katherine Bremner2, Zane Wang1, Chuanmin Wang1, Szun Szun Tay2, Claire McGuffog2, Grant J Logan3, Ian E Alexander3,4, Min Hu5, Stephen I Alexander6, Tim D Sparwasser7, Patrick Bertolino2, David G Bowen1,2, G Alex Bishop1, Alexandra Sharland1.   

Abstract

Adeno-associated viral vector-mediated (AAV-mediated) expression of allogeneic major histocompatibility complex class I (MHC class I) in recipient liver induces donor-specific tolerance in mouse skin transplant models in which a class I allele (H-2Kb or H-2Kd) is mismatched between donor and recipient. Tolerance can be induced in mice primed by prior rejection of a donor-strain skin graft, as well as in naive recipients. Allogeneic MHC class I may be recognized by recipient T cells as an intact molecule (direct recognition) or may be processed and presented as an allogeneic peptide in the context of self-MHC (indirect recognition). The relative contributions of direct and indirect allorecognition to tolerance induction in this setting are unknown. Using hepatocyte-specific AAV vectors encoding WT allogeneic MHC class I molecules, or class I molecules containing a point mutation (D227K) that impedes direct recognition of intact allogeneic MHC class I by CD8+ T cells without hampering the presentation of processed peptides derived from allogeneic MHC class I, we show here that tolerance induction depends upon recognition of intact MHC class I. Indirect recognition alone yielded a modest prolongation of subsequent skin graft survival, attributable to the generation of CD4+ Tregs, but it was not sufficient to induce tolerance.

Entities:  

Keywords:  Antigen presentation; Gene therapy; Hepatology; Tolerance; Transplantation

Mesh:

Substances:

Year:  2018        PMID: 30089715      PMCID: PMC6129134          DOI: 10.1172/jci.insight.97500

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  66 in total

1.  Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide.

Authors:  Kazuhito Honjo; Xiao Yan Xu; Judith A Kapp; R Pat Bucy
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

2.  Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs.

Authors:  Alexandra Sharland; Amy Patel; Josie Han Lee; Aimee E Cestra; Susan Saidman; Gerald L Waneck
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.

Authors:  K Lee; V Nguyen; K-M Lee; S-M Kang; Q Tang
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

4.  Liver-Specific Allergen Gene Transfer by Adeno-Associated Virus Suppresses Allergic Airway Inflammation in Mice.

Authors:  Cheng-Chi Chan; Chin-Wen Lai; Chia-Jen Wu; Li-Chen Chen; Mi-Hua Tao; Ming-Ling Kuo
Journal:  Hum Gene Ther       Date:  2016-08       Impact factor: 5.695

5.  Gene delivery to the juvenile mouse liver using AAV2/8 vectors.

Authors:  Sharon C Cunningham; Allison P Dane; Afroditi Spinoulas; Grant J Logan; Ian E Alexander
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

Review 6.  Promoting transplantation tolerance; adoptive regulatory T cell therapy.

Authors:  N Safinia; J Leech; M Hernandez-Fuentes; R Lechler; G Lombardi
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

7.  Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs.

Authors:  Mahzad Akbarpour; Kevin S Goudy; Alessio Cantore; Fabio Russo; Francesca Sanvito; Luigi Naldini; Andrea Annoni; Maria Grazia Roncarolo
Journal:  Sci Transl Med       Date:  2015-05-27       Impact factor: 17.956

8.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.

Authors:  Katharina Lahl; Christoph Loddenkemper; Cathy Drouin; Jennifer Freyer; Jon Arnason; Gérard Eberl; Alf Hamann; Hermann Wagner; Jochen Huehn; Tim Sparwasser
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

Review 9.  Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.

Authors:  L A Smyth; B Afzali; J Tsang; G Lombardi; R I Lechler
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

10.  The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).

Authors:  C Kurts; W R Heath; H Kosaka; J F Miller; F R Carbone
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  5 in total

1.  Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity.

Authors:  Laurent Bartolo; Stéphanie Li Chung Tong; Pascal Chappert; Dominique Urbain; Fanny Collaud; Pasqualina Colella; Isabelle Richard; Giuseppe Ronzitti; Jocelyne Demengeot; David A Gross; Federico Mingozzi; Jean Davoust
Journal:  JCI Insight       Date:  2019-06-06

2.  The self-peptide repertoire plays a critical role in transplant tolerance induction.

Authors:  Eric T Son; Pouya Faridi; Moumita Paul-Heng; Mario L Leong; Kieran English; Sri H Ramarathinam; Asolina Braun; Nadine L Dudek; Ian E Alexander; Leszek Lisowski; Patrick Bertolino; David G Bowen; Anthony W Purcell; Nicole A Mifsud; Alexandra F Sharland
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

Review 3.  Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects.

Authors:  Hong Lei; Petra Reinke; Hans-Dieter Volk; Yi Lv; Rongqian Wu
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

4.  Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle.

Authors:  Jérôme Poupiot; Helena Costa Verdera; Romain Hardet; Pasqualina Colella; Fanny Collaud; Laurent Bartolo; Jean Davoust; Peggy Sanatine; Federico Mingozzi; Isabelle Richard; Giuseppe Ronzitti
Journal:  Mol Ther Methods Clin Dev       Date:  2019-09-03       Impact factor: 6.698

5.  Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8+ T Cell Tolerance Development.

Authors:  Martina Damo; D Scott Wilson; Elyse A Watkins; Jeffrey A Hubbell
Journal:  Front Immunol       Date:  2021-03-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.